George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 288.00
Bid: 285.60
Ask: 286.60
Change: -2.20 (-0.76%)
Spread: 1.00 (0.35%)
Open: 289.00
High: 299.40
Low: 285.20
Prev. Close: 290.20
GBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GB GROUP PLC

7 Oct 2022 10:11

RNS Number : 1693C
Charles Stanley & Co. Ltd.
07 October 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Charles Stanley & Co. Ltd

(on behalf of discretionary clients)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

GB Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

n/a

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

6th October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ord 1p

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,554,887

 

1.80%

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

4,554,887

1.80%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ord 2.5p

Sale

4465

485.48p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

07th October 2022

Contact name:

Rennie Veiga

Telephone number*:

020 7149 6961

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFSWSUWEESESS
Date   Source Headline
26th Apr 20242:33 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSFY24 trading update
28th Mar 202412:47 pmRNSTotal Voting Rights
29th Feb 20243:44 pmRNSTotal Voting Rights
31st Jan 20244:59 pmRNSDirector/PDMR Shareholding
31st Jan 20241:00 pmRNSTotal Voting Rights
30th Jan 20247:00 amRNSDirectorate change and in-line trading update
26th Jan 20248:30 amRNSHolding(s) in Company
19th Jan 202410:01 amRNSBlock listing Interim Review
29th Dec 202311:54 amRNSTotal Voting Rights
19th Dec 20238:50 amRNSHolding(s) in Company
4th Dec 20231:49 pmRNSDirector/PDMR Shareholding
30th Nov 20232:12 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
31st Oct 20233:15 pmRNSTotal Voting Rights
23rd Oct 20232:12 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSHalf-year trading update
29th Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20232:03 pmRNSTotal Voting Rights - Correction
31st Aug 20237:00 amRNSTotal Voting Rights
10th Aug 20234:47 pmRNSPDMR shareholding, Issue of Ordinary Shares & TVR
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 202312:26 pmRNSResult of AGM
20th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSBlock listing Interim Review
14th Jul 20232:13 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20235:24 pmRNSPosting of Annual Report and Notice of AGM
15th Jun 20237:00 amRNSFinal Results
31st May 20237:00 amRNSTotal Voting Rights
2nd May 20232:01 pmRNSTotal Voting Rights
24th Apr 20237:00 amRNSDirector Dealing
20th Apr 20237:00 amRNSPre-close trading update
6th Apr 20233:01 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202312:59 pmRNSHolding(s) in Company
24th Mar 20238:58 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSDirector Retirement
28th Feb 20237:00 amRNSTotal Voting Rights
22nd Feb 20237:00 amRNSDirector Dealing
21st Feb 20237:00 amRNSTrading update
7th Feb 20237:00 amRNSBlock listing Interim Review
31st Jan 20237:00 amRNSTotal Voting Rights
24th Jan 20233:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSCapital Markets Event
29th Nov 20227:00 amRNSHalf-year Report
11th Nov 20228:42 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSHolding(s) in Company
1st Nov 202212:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.